Drugs / BioRBC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06788080 | Mar → Nov 2024 | — | Vitalant Research Institute | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BioRBC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06788080 ↗ |
| Route | Other | “Autologous biotin-labeled RBCs will be transfused to study participants” NCT06788080 ↗ |